Navigation Links
OneTouch(R) Ping(TM) Glucose Management System Approved by Health Canada

VANCOUVER, July 15 /PRNewswire/ -- Animas Corporation announced today the approval of its OneTouch((R)) Ping(TM) Glucose Management System by Health Canada. OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

"OneTouch Ping provides patients with unique capabilities designed to make life with diabetes easier and more discreet. A combination of the advanced insulin pump technology from Animas and trusted OneTouch blood glucose monitor technology, the OneTouch Ping frees people living with diabetes from multiple daily injections, while offering discretion and convenience through remote insulin dosing," said Henry Anhalt, D.O., Director of Medical Affairs, Animas Corporation. "Animas is pleased to bring this advancement to people with diabetes in Canada."

OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson: Animas makers of insulin pumps and LifeScan makers of the OneTouch brand of glucose meters and OneTouch((R)) Ultra((R)) Test Strips.

OneTouch Ping also offers the following:

  • Lifestyle-focused pump performance - the pump can be clipped to a belt, tucked in a pocket, or secured under clothing, is waterproof up to 3.6 meters (12 feet) for 24 hours, and has a color screen for outstanding pump readability
  • Individualized control - delivers lowest basal increments (0.025 U/hr) and lowest bolus increments (0.05 U) available to more precisely match patient insulin needs
  • Proven blood glucose monitoring technology - the meter-remote utilizes the OneTouch((R)) Ultra((R)) test strip, the #1-selling test strip in Canada and #1 test strip preferred among insulin users in Canada.( )OneTouch((R)) Ultra((R)) test strips have more than 6 years of proven accuracy and use patented DoubleSure(TM) technology to automatically check and confirm results for accuracy

ezManager((R)) MAX Diabetes Management Software

The OneTouch Ping system will also work with the ezManager((R)) MAX Diabetes Management Software designed to allow users to download important diabetes management data from the insulin pump and meter-remote. Integrated blood glucose data from the meter-remote and insulin dosing data may be downloaded for review, analysis and evaluation of insulin delivery and blood glucose history to better inform healthcare decision-making. The ezManager((R)) MAX software is MAC and PC compatible.

OneTouch Ping will be available for shipment on Friday, July 24. Customers can order at any time by calling 1-866-406-4844 or by visiting

About Animas Corporation

As part of the Johnson & Johnson Family of Companies, Animas is dedicated to creating a world without limits for people with diabetes through a wide range of products, including the Animas 2020 insulin pump, inset 30 infusion set, ezManager MAX software and the new OneTouch Ping glucose management system. Animas, from the Latin word meaning true inner self or soul, has been committed since 1996 to individual patient needs through the development of life-performance technology and unparalleled customer service live 24 hours a day, 7 days a week, 365 days a year.

To learn more about Animas and its products available in Canada, visit

About LifeScan, Inc.

LifeScan, Inc., a Johnson & Johnson company and the leading maker of blood glucose monitoring products, is dedicated to creating a world without limits for people with diabetes. The company develops, manufactures, and markets a wide range of glucose monitoring systems and software for use by people with diabetes and health care providers.

For healthcare professional resources, and information on diabetes care and LifeScan products and services, visit

SOURCE Animas Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. OneTouch(R) Laugh & Learn Sweepstakes to Award Scholarships for Summer Camp Experiences to Children with Diabetes
2. OneTouch(R) Ping(TM) Glucose Management System Cleared by FDA
3. Photos: OneTouch(R) Features Five Participants From Global Diabetes Handprint Project in National Awareness and Fundraising Campaign
4. *** Diabetes Alert Day *** OneTouch(R) Offers Cost Saving Tips to Help Diabetes Patients Maintain Good Health in Tough Economy
5. Scientists explain how insulin secreting cells maintain their glucose sensitivity
6. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
7. Increased glucose level is a strong risk factor for colorectal cancer
8. Got sugar? Glucose affects our ability to resist temptation
9. Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
11. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
(Date:11/27/2015)... ... ... According to an article published November 13th on, much ... revolved around the fact that proper dental care, both at-home and in the dental ... periodontal disease (more commonly referred to as gum disease) and diabetes. According to Dr. ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse ... the findings on the website. Click here to read the details now. ... who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was ... inventor from Hillside, N.J. "Many people catch diseases simply from sitting on such ... always be protected from germs." , He developed the patent-pending QUDRATECS to eliminate ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... November 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South ... 750,000. The digital component is distributed nationally, through a vast social media strategy ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Monitoring (TDM) Market: Supplier Shares, Country ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
Breaking Medicine Technology: